Announcement on Subsidiary Obtaining Notice of Approval for Drug Clinical Trials
Release time:
2021-05-20
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No: pro 2021-001
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Subsidiaries Obtaining Drug Clinical Trial Approval Notice
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Important Note:
- Company's approval notice for drug clinical trials will not have a significant impact on the company's recent operating results.
- Risk Warning: Due to the particularity of drug research and development, the pre-development of drugs and the long cycle and many links of products from development, clinical trials to production are susceptible to some uncertain factors, clinical trial progress, There are many uncertainties in the results and the future product market competition situation.
1. Summary
Recently, Zhejiang Erying Pharmaceutical Co., Ltd. (hereinafter referred to as "Erying Company") and , the controlling subsidiary of Zhejiang Jianfeng Pharmaceutical Co., Ltd., the controlling subsidiary of the Company, received the Notice of Approval for Clinical Trials of Drugs approved and issued by the State Drug Administration. The relevant details are hereby announced as follows:
2. drug basic information content
drug name: acetaminophen suppository
English name: Paracetamol Suppositories
dosage form: suppository
application classification: generic drug application
specification: 75mg , 125mg
registration classification: chemical drugs category 3
applicant: Zhejiang erying drug co., ltd.
approval conclusion: "according to the the People's Republic of China drug administration law and relevant regulations, after examination, the acetaminophen suppository accepted on 2020 5 February 13 meets the relevant requirements for drug registration, it is recommended that the bioequivalence study of this product be carried out in healthy adults with a single fasting dose, and that the study of BE be exempted under different specifications to meet pharmaceutical requirements."
3. Drug Research and Development and Investment
Acetaminophen Suppository is an antipyretic analgesic developed by Erying Company. Its registered classification belongs to chemical drug 3 . Acetaminophen Suppository is indicated for fever caused by common cold or influenza in children, and is also used for relieving mild to moderate pain such as headache, arthralgia, migraine, toothache, myalgia and neuralgia. As of the date of this announcement, the accumulated research and development expenses and technical investment of the project totaled about RMB ,788.09 . Market Situation of
4. Similar Drugs
Acetaminophen Suppository was first developed by German Bene Company and listed in Germany in 1960 . In 2019 , the dosage of German acetaminophen Suppository was about 1.08 .6 billion tablets (data source: IMS ). At present, paracetamol suppositories of infant specifications have been listed in many countries in the world. At present, paracetamol suppositories of 125 mg , 150 mg , 300 mg and 600 mg have been listed in China, of which 125 mg and 150 mg are used for fever caused by common cold or influenza in children aged 1-6 , no paracetamol suppositories exist for infants and young children aged 0-1 years. Acetaminophen suppository (75 mg ) developed by Erying Company is suitable for antipyretic and analgesic treatment for infants aged 0-1 years old in China. Acetaminophen suppository (125 mg ) is suitable for infants aged 6 months to 2 years old (administered according to age and weight). Scientifically administered acetaminophen suppository will be provided for infants aged 0-2-2-116 years old. Approval Procedures to Be Performed for Listing of 5. Products
Er Ying Company will conduct clinical trials (bioequivalence studies) according to the requirements of the Notice of Approval of Drug Clinical Trials. After the clinical trials are completed, it will apply for production. After passing the review and approval of the State Food and Drug Administration and obtaining the approval documents for drug production, it can produce
products and go on sale. 6. Impact on Listed Companies and Risk Tips
The company's approval notice for drug clinical trials will not have a significant impact on the company's recent operating results. Due to the particularity of drug research and development, the pre-development of drugs and the long cycle and many links from development, clinical trials to production of products are easily affected by some uncertain factors. There are many uncertainties in the progress and results of clinical trials and the future product market competition situation. The company will be based on the progress of research and development in a timely manner to fulfill the obligations of information disclosure, so that the majority of investors pay attention to investment risks.
hereby announce
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
January 6, 2001
More information
Daye Peak Won "Advanced Manufacturing Brand" in Huangshi City"
On the occasion of the fifth "China Brand Day", the office of Huangshi City Quality Strong City Working Committee held a grand awarding ceremony of "Promoting the High-quality Development of Huangshi 70 Brands", and Daye Jianfeng Cement Company was awarded the "Advanced Manufacturing Brand". In order to revitalize the post-epidemic economy and enhance the confidence of enterprises, Huangshi City Quality Strong City Working Committee Office organized and carried out a large-scale news investigation, publicity and exhibition activity of "Huangshi Glory, the era of glory-the 70th anniversary of the founding of the city, promoting the high-quality development of Huangshi 70 brands", aiming at vigorously publicizing the major achievements and advanced models of the high-quality development of various industries in Huangshi and the construction of strong quality strong quality city, and encouraging enterprises, and leading enterprises to further establish the strong quality, help Yellowstone "five city construction", cohesion of economic and social high-quality development of a strong force. After the public vote, the 70 brands and 30 characteristic brands selected to promote the high-quality development of Huangshi in the 70 years since the establishment of the city were awarded the advanced manufacturing brand, modern service brand, high-quality education brand, excellent cultural brand, modern agricultural brand and Huangshi high-quality development characteristic brand respectively. Daye Peak won the honor of "advanced manufacturing brand.
2021
05-21
Learning Party History, Strong Faith
On April 29, the staff of the peak building stopped to browse when they passed the newly created party history knowledge propaganda wall. 2021 is the 100 anniversary of the founding of the Communist Party of China, the Central Committee called on the whole party to carry out the study and education of party history. Since the party committee of the group company deployed the party history study and education work, party organizations at all levels of the company have taken active actions to further strengthen their ideals and beliefs through various forms such as special party classes, concentrated study, visiting the red education base, and reviewing the oath of joining the party.
2021
05-06
Cement industry, Huangshi City two honors flower daye peak
In April, China's cement industry and Huangshi City in Hubei Province each won an honor by Daye Peak, and the company's work in environmental protection and poverty alleviation was affirmed. The 2021 China Cement Industry Summit held in Hangzhou from April 20 to 21, with the theme of "common mission, innovation and common development", discussed the current development trend of the cement industry in depth. During the meeting, a series of awards for the top 100 cement industry were held. After reviewing multi-dimensional information such as brand growth, brand productivity, brand awareness and brand reputation, daye peak was awarded the title of "enterprise with outstanding contribution to environmental protection. Recently, Huangshi City Federation of Industry and Commerce (Chamber of Commerce) held the 6th Executive Committee of the 12th session to review the work in 2020 and deploy the targets and tasks for 2021. It commended the city's advanced collective of "precise poverty alleviation and private enterprise assistance". Daye Peak was awarded the honorary title of "Advanced Private Enterprise.
2021
05-06
Yang Zhi, head of Huangping County, Guizhou Province, visited Jianfeng
On April 16, a delegation led by Yang Zhi, head of Huangping County, Guizhou Province, visited the headquarters of the group company and held discussions with the group leaders on the future development of Huangping peak and further strengthening the in-depth cooperation between the two sides. During the exchange, Chairman Jiang Xiaomeng introduced the development of Jianfeng in recent years, which aroused unanimous praise from the members of the delegation. Yang Zhi said that Jianfeng is an enterprise with a sense of social responsibility and serious business. He hopes to further cooperate in other industrial fields to promote the economic development of Huangping.
2021
04-21
The Pursuit and Dream of the Spike of "Egoist" of "Lie to the People"
On March 23, China Cement Network published an exclusive interview with Jiang Xiaomeng, chairman of the group company, under the title of "the pursuit and Dream of the peak of self-interest. During the interview, Jiang Xiaomeng expressed his views on the future development trend of China's cement industry and introduced the development ideas of the peak cement industry in the future. The full text of this article is reproduced here...
2021
04-12
Daye Peak Won the Title of "Charity Enterprise" in Daye City
Daye city recently organized the 2020 Metallurgical Conference to review and summarize the 2020 Metallurgical Work and arrange the deployment of 2021. Wang Gang, secretary of the Daye Municipal Party Committee, attended the conference and made an important speech, in particular, he expressed his heartfelt thanks to a group of enterprises and entrepreneurs, such as Jinpai Company and Daye Peak, for coming forward, giving generously and helping at the most critical juncture of Daye epidemic prevention and control. The conference announced the "Decision of Daye Municipal Party Committee and Municipal Government on Releasing the 2020 Charity Contribution List" and commended it on the spot. Daye Peak and other enterprises were awarded the honorary title of "2020 Charity Enterprise. Zhang Fengliang, deputy general manager of the group company and general manager of Daye Peak, accepted the commendation on behalf of Daye Peak and delivered a keynote speech at the meeting as a representative of the commended enterprise. (Daye Peak)
2021
04-12